Acumen Pharmaceuticals
ABOS
ABOS
69 hedge funds and large institutions have $61.1M invested in Acumen Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 27 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
3.09% less ownership
Funds ownership: 62.08% → 58.99% (-3.1%)
67% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 27
Holders
69
Holding in Top 10
–
Calls
$48K
Puts
$3K
Top Buyers
| 1 | +$845K | |
| 2 | +$691K | |
| 3 | +$577K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$131K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$128K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$1.32M | |
| 3 | -$341K | |
| 4 |
Goldman Sachs
New York
|
-$321K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$291K |
